Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 943-952

  Sircar, Ratna ^a   Soliman, Karam F A ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Brain development; Dopaminergic system; NMDA antagonist; Phencyclidine

Indexed keywords

DOPAMINE 2 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BRAIN DEVELOPMENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; SEX; STEREOTYPY;

ATAXIA;

EID: 0037345192     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00025-X     Document Type: Article

References (70)

1. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:1998;5545-5554.
2. Adriani W., Felici A., Sargolini F., Roullet P., Usiello A., Oliverio A.et al. N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp. Brain Res. 123:1998;52-59.
3. Anis N.A., Berry S.C., Burton N.R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharmacol. 79:1983;565-575.
4. Bartschat D.K., Blaustein M.P. Phencyclidine in low-doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain. Proc. Natl. Acad. Sci. U. S. A. 83:1986;189-192.
5. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64:1999;803-812.
6. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensin increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-661.
7. Castellani S., Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. 73:1981;143-154.
8. Chen G., Ensor C.R., Russel D., Bohnier B. The pharmacology of (1-(phenylcyclohexyl) piperidine HCl. J. Pharmacol. Exp. Ther. 127:1959;241-250.
9. Cook C.E., Brine D.R., Jeffcoat A.R., Hill J.M., Wall M.E., Perez-Reyes M.et al. Phencyclidine disposition after intravenous and oral doses. Clin. Pharmacol. Ther. 31:1982;625-634.
10. Dall'Olio R., Gandolfi O., Montanaro N. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology. 107:1992;591-594.
11. Dall'Olio R., Facchinetti F., Contestabile A., Gandolfi O. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat. Neuroscience. 63:1994;451-455.
12. Deutch A.Y., Tam S.-Y., Freeman A.S., Bowyers M.B. Jr., Roth R.H. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur. J. Pharmacol. 134:1987;257-264.
13. Dobbing J., Hopewell J.W., Lynch A. Vulnerability of developing brain: VII. Permanent deficit of neurons in cerebral and cerebellar cortex following early mild undernutrition. Exp. Neurol. 32:1971;439-447.
14. Doherty J., Simonovic M., So R., Meltzer H. The effects of phencyclidine on dopamine synthesis and metabolism in rat striatum. Eur. J. Pharmacol. 65:1980;139-149.
15. Druhan J.P., Rajabi H., Stewart J. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse. 24:1996;135-146.
16. D'Souza D.N., Harlan R.E., Garcia M.M. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-fos induction in the rat brain. Neuroscience. 93:1999;1539-1547.
17. Emerich D.F., Zubrycki E.M., Shipley M.T., Norman A.B., Sanberg P.R. Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striatal lesions: effects of striatal transplants. Exp. Neurol. 11:1991;369-378.
18. Facchinetti F., Dall'Olio R., Ciani E., Sparapani M., Virgili M., Contestabile A.et al. Long lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats. Neuroscience. 60:1994;343-353.
19. Fagg G.E. Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes. Neurosci. Lett. 76:1987;221-227.
20. Fico T.A., Vanderwende C. Phencyclidine during pregnancy: fetal brain levels and neurobehavioral effects. Neurotoxicol. Teratol. 10:1988;349-354.
21. Freed W.J., Weinberger D.R., Bing L.A., Wyatt R.J. Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology. 71:1980;291-297.
22. Freeman A.S., Bunney B.S. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur. J. Pharmacol. 104:1984;287-293.
23. 2 dopamine receptor function in rat striatum. Pharmacol. Biochem. Behav. 4:1993;683-687.
24. Gershanik O., Heikkila R.E., Duvoisin R.C. Behavioral correlations of dopamine receptor activation. Neurology. 33:1983;1489-1492.
25. Giordano M., Mejía-Viggiano M.C. Gender differences in spontaneous and MK-801-induced activity after striatal lesions. Brain Res. Bull. 56:2001;553-561.
26. Gorter J.A., de Bruin J.P.C. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in adult rat. Brain Res. 580:1992;12-17.
27. Hertel P., Mathé J.M., Nomikos G.G., Iurlo M., Mathé A.A., Svensson T.H. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72:1996;103-114.
28. Hiramatsu M., Cho A.K., Nabeshima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:1989;359-366.
29. Honack D., Loscher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620:1993;167-170.
30. Hondo H., Yonezawa T., Nakahata T., Nakamura K., Hirano M., Uchimura H.et al. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 633:1994;337-342.
31. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1991;1301-1308.
32. Kanner M., Meltzer H.Y., Davis J.M. Pharmacologic aspects of the locomotor stimulation produced by phencyclidine in the rat. SFN Neurosci. Abstr. 1:1975;366.
33. Kitaichi K., Yamada K., Hasegawa T., Furukawa H., Nabeshima T. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Jpn. J. Pharmacol. 66:1994;181-189.
34. Krystal J., Karper L., Bennett A., Abi-Saab D., Souza C., Abi-Dargham A.et al. Modulating ketamine-induced thought disorder with lorazepam and haloperidol in humans. Schizophr. Pre. 15:1995;156.
35. Lewis P., Patel A.J., Balázs R. Effect of undernutrition on cell generation in the rat hippocampus. Brain Res. 168:1979;186-189.
36. Liljequist S., Ossowska K., Grabowska-Anden M., Anden N.E. Effect of the NMDA receptor antagonist MK-801 on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol. 195:1991;55-61.
37. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
38. Marcus M.M., Mathé J.M., Nomikos G.G., Svensson T.H. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology. 40:2001;482-490.
39. Marichich E.S., Molina V.A., Orsingher O.A. Persistent changes in central catecholaminergic systems after recovery of perinatally undernourished rats. J. Nutr. 109:1979;1045-1050.
40. Mele A., Thomas N.D., Pert A. Different mechanisms underlie MK-801 and dopamine agonist induced locomotor activity. Neuroscience. 82:1998;43-58.
41. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
42. Noda A., Noda Y., Ichihara K., Mamiya T., Nagai T., Sugiura S., Furukawa H., Nabeshima T. Phencyclidine impairs learning in mice: interaction between glutamatergic systems and sigmal receptors. Neuropsychopharmacol. 24:2001;451-460.
43. Proksch J.W., Gentry W.B., Owens S.M. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metab. Dispos. 28:2000;742-747.
44. Ramanamurthy P.S. Maternal and early postnatal malnutrition and transmitter amines in rat brain. J. Neurochem. 28:1977;253-254.
45. Schmidt W.J., Zadow B., Kretschmer B.D., Hamber W. Anticataleptic potencies of glutamate-antagonists. Amino Acids. 1:1991;225-237.
46. Semba J., Tanaka N., Wakuta M., Suhara T. Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain. Synapse. 40:2001;11-18.
47. Shoemaker W., Wurtman R. Perinatal undernutrition: accumulation of catecholamines in rat brain. Science. 171:1971;1017-1019.
48. Sircar R. Chronic postnatal phencyclidine administration in female rat delays onset of puberty but has no effect on pentylenetetrazol-induced seizure-susceptibility. Brain Res. 694:1995;318-321.
49. Sircar R. Postnatal phencyclidine treatment in rats dose-dependently affects spatial learning and memory. SFN Abstr. 31:2001;319.6.
50. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int. J. Dev. Neurosci. 2003;. [in press].
51. Sircar R., Li C.-S. PCP/NMDA receptor-channel complex and brain development. Neurotoxicol. Teratol. 16:1994;369-375.
52. Sircar R., Rudy J.W. Repeated neonatal phencyclidine treatment impairs performance of a spatial task in juvenile rats. Ann. N. Y. Acad. Sci. 844:1998;303-309.
53. 3H]TCP binding in rat brain by light microscopy autoradiography. Brain Res. 344:1985;142-145.
54. 3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"σ opiate" receptor commonality. J. Pharmacol. Exp. Ther. 237:1986;681-688.
55. Sircar R., Rappaport M., Nichtenhauser R., Zukin S.R. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/σ-receptors. Brain Res. 435:1987;235-248.
56. Sircar R., Veliskova J., Moshe S.L. Chronic neonatal phencyclidine treatment results in age-related changes in pentylenetetrazol-induced seizures. Dev. Brain Res. 81:1994;185-191.
57. 3H](+)pentazocine binding in juvenile rat brain. Dev. Brain Res. 88:1995;224-226.
58. Sircar R., Follesa P., Ticku M.K. Chronic neonatal PCP differentially regulates mRNA levels for NMDA receptor subunits. Mol. Brain Res. 40:1996;214-220.
59. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 59:1979;169-179.
60. Tomić M., Vukosavić S., Joksimović J. Acute amphetamine and/or phencyclidine effects on the dopamine receptor specific binding in rat brain. Eur. Neuropharmacol. 7:1997;295-301.
61. Tonge S.R., Leonard B.E. Partial antagonism of the behavioral and neurochemical effects of phencyclidine by drugs affecting monoamine metabolism. Psychopharmacologia. 24:1972;516-520.
62. Tonkiss J., Smart J.L., Massey R.F. Effects of early life undernutrition in artificially reared rats: 2. Subsequent behavior. Physiol. Behav. 41:1987;555-562.
63. Valentine J.L., Owens S.M. Antiphencyclidine monoclonal antibodies significantly change phencyclidine concentrations in brain and other tissues in rats. J. Pharmacol. Exp. Ther. 278:1996;717-724.
64. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alteration performance in rats: modulation by dopamine. J. Neurosci. 16:1996;373-379.
65. Vincent J.P., Cavey D., Kamenka J.M., Geneste P., Lazdunski M. Interactions of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Brain Res. 152:1978;176-182.
66. Wessinger W.D., Owens S.M. Chronic administration of phencyclidine of phencyclidine: pharmacokinetic comparison of intravenous and subcutaneous infusions in Sprague-Dawley rats. Drug Metab. Dispos. 19:1991;719-721.
67. Wessinger W.D., Owens S.M. Phencyclidine dependence: the relationship of dose and serum concentration to operant behavioral effects. J. Pharmacol. Exp. Ther. 258:1991;207-215.
68. Woodworth J.R., Owens S.M., Mayersohn M. Phencyclidine disposition kinetics in dogs as a function of dose and route of administration. J. Pharmacol. Exp. Ther. 234:1985;654-661.
69. Xu X., Domino E.F. A further study on asymmetric cross-sensitization between MK-801 and phencyclidine-induced ambulatory activity. Pharmacol. Biochem. Behav. 63:1999;413-416.
70. Zagon I.S., McLaughlin P.J. Comparative effects of postnatal undernutrition and methadone exposure on protein and nucleic acid contents of the brain and cerebellum in rats. Dev. Neurosci. 5:1982;385-393.